TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy

International Journal of Pharmaceutics

Volumn 476, Issue 1, 2014, Pages 185-198

  Zhang, Jinming ^a   Li, Yingbo ^a,b   Fang, Xiefan ^c   Zhou, Demin ^b   Wang, Yitao ^a   Chen, Meiwan ^a  

^a China jack1987168 163com   (Macao)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer therapy; Mixed micelles; Pluronic F68; Tanshinone IIA; TPGS

Indexed keywords

CASPASE 3; COPOLYMER; DEXTRO ALPHA TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE GRAFT POLY(DEXTRO LEVO LACTIDE CO GLYCOLIDE); POLOXAMER; TANSHINONE IIA; UNCLASSIFIED DRUG; ABIETANE DERIVATIVE; ALPHA TOCOPHEROL; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; DELAYED RELEASE FORMULATION; DRUG CARRIER; LACTIC ACID; MACROGOL DERIVATIVE; MICELLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TANSHINONE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CHEMICAL STRUCTURE; CHROMOSOME CONDENSATION; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MICELLE; MITOCHONDRIAL MEMBRANE POTENTIAL; NANOENCAPSULATION; NONHUMAN; RAT; SUSTAINED DRUG RELEASE; SYNTHESIS; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOLOGICAL AVAILABILITY; CARCINOMA, HEPATOCELLULAR; DELAYED-ACTION PREPARATIONS; DITERPENES, ABIETANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEP G2 CELLS; HUMANS; LACTIC ACID; LIVER NEOPLASMS; MALE; MICELLES; POLOXAMER; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; VITAMIN E;

EID: 84907985544     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.09.017     Document Type: Article

References (62)

1. G. Barratt Characterization of colloidal drug carrier systems with zeta potential measurements Pharm. Technol. Eur. 1999 25 32
2. G. Basu Ray, I. Chakraborty, and S.P. Moulik Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity J. Colloid Interface Sci. 294 2006 248 254
3. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
4. E.V. Batrakova, S. Li, A.M. Brynskikh, A.K. Sharma, Y. Li, M. Boska, N. Gong, R.L. Mosley, V.Y. Alakhov, and H.E. Gendelman Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Control. Release 143 2010 290 301
5. X. Chen, Z.W. Zhou, C. Xue, X.X. Li, and S.F. Zhou Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier Xenobiotica 37 2007 635 678
6. X. Chen, J. Guo, J. Bao, J. Lu, and Y. Wang The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review Med. Res. Rev. 2013
7. S. Chiu, S. Huang, S. Chen, C. Su, T. Chiu, and C. Pang Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo Prostate Cancer Prostatic Dis. 16 2013 315 322
8. T. Chu, Q. Zhang, H. Li, W.C. Ma, N. Zhang, H. Jin, and S.J. Mao Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro Int. J. Pharm. 424 2012 76 88
9. E.M. Collnot, C. Baldes, M.F. Wempe, R. Kappl, J. Hüttermann, J.A. Hyatt, K.J. Edgar, U.F. Schaefer, and C.M. Lehr Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity Mol. Pharm. 4 2007 465 474
10. S. Dash, P.N. Murthy, L. Nath, and P. Chowdhury Kinetic modeling on drug release from controlled drug delivery systems Acta Pol. Pharm. 67 2010 217 223
11. J. Drbohlavova, J. Chomoucka, V. Adam, M. Ryvolova, T. Eckschlager, J. Hubalek, and R. Kizek Nanocarriers for anticancer drugs-new trends in nanomedicine Current Drug Metab. 14 2013 547 564
12. A.B. Ebrahim Attia, Z.Y. Ong, J.L. Hedrick, P.P. Lee, P.L.R. Ee, P.T. Hammond, and Y.-Y. Yang Mixed micelles self-assembled from block copolymers for drug delivery Current Opin. Colloid Interface Sci. 16 2011 182 194
13. S. Emanuele, M. Lauricella, D. Carlisi, B. Vassallo, A. D'Anneo, P. Di Fazio, R. Vento, and G. Tesoriere SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib Apoptosis 12 2007 1327 1338
14. Y. Fu, and W.J. Kao Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems Expert Opin. Drug Deliv. 7 2010 429 444
15. Y. Gao, L.B. Li, and G. Zhai Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin Colloids Surf. B: Biointerfaces 64 2008 194 199
16. Y.W. He, H.S. Wang, J. Zeng, X.F. Fang, H.Y. Chen, J. Du, and X.Y. Yang Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells Life Sci. 93 2013 509 515
17. I. Herr, and K.-M. Debatin Cellular stress response and apoptosis in cancer therapy Blood 98 2001 2603 2614
18. S. Honary, and F. Zahir Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1) Trop. J. Pharm. Res. 12 2013 255 264
19. Y. Hu, S. Wang, X. Wu, J. Zhang, R. Chen, M. Chen, and Y. Wang Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma J. Ethnopharmacol. 149 2013 601 612
20. C.Y. Huang, T.L. Chiu, S.J. Kuo, S.Y. Chien, D.R. Chen, and C.C. Su Tanshinone IIA inhibits the growth of pancreatic cancer BxPC-3 cells by decreasing protein expression of TCTP, MCL-1 and Bcl-xL Mol. Med. Rep. 7 2013 1045 1049
21. W. Jiang, B.Y. Kim, J.T. Rutka, and W.C. Chan Nanoparticle-mediated cellular response is size-dependent Nature Nanotechnol. 3 2008 145 150
22. ® block copolymers as novel polymer therapeutics for drug and gene delivery J. Control. Release 82 2002 189 212
23. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
24. ® F-68 enhances the nanoparticle-cell interaction Sci. Pharm. 77 2009 179
25. K.S. Kim, and S.J. Park Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol Colloids Surf. B: Biointerfaces 80 2010 240 246
26. S. Kollipara, G. Bende, S. Movva, and R. Saha Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel Drug Dev. Ind. Pharm. 36 2010 1377 1387
27. H. Kuang, S. Wu, Z. Xie, F. Meng, X. Jing, and Y. Huang Biodegradable amphiphilic copolymer containing nucleobase: synthesis, self-assembly in aqueous solutions, and potential use in controlled drug delivery Biomacromolecules 13 2012 3004 3012
28. S. Kulthe, N. Inamdar, Y. Choudhari, S. Shirolikar, L. Borde, and V. Mourya Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery Colloids Surf. B: Biointerfaces 88 2011 691 696
29. W.Y. Lee, K.W. Liu, and J.H. Yeung Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells Cancer Lett. 285 2009 46 57
30. S.D. Li, and L. Huang Nanoparticles evading the reticuloendothelial system: role of the supported bilayer Biochim. Biophys. Acta (BBA) - Biomembr. 1788 2009 2259 2266
31. Y. Li, and G.S. Kwon Methotrexate esters of poly(ethylene oxide)-block-poly (2-hydroxyethyl-l-aspartamide). Part I: effects of the level of methotrexate conjugation on the stability of micelles and on drug release Pharm. Res. 17 2000 607 611
32. Q. Li, Y. Wang, N. Feng, Z. Fan, J. Sun, and Y. Nan Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma J. Drug Target. 16 2008 725 732
33. Y. Li, Z. Wang, X. Yan, M. Chen, J. Bao, G. Wu, Z. Ge, D. Zhou, Y. Wang, and R. Li IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities Cancer Lett. 340 2013 88 96
34. H. Lian, T. Zhang, J. Sun, X. Liu, G. Ren, L. Kou, Y. Zhang, X. Han, W. Ding, and X. Ai Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism Mol. Pharm. 10 2013 3447 3458
35. J. Liu, F. Zeng, and C. Allen Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent J. Control. Release 103 2005 481 497
36. J. Ly, D. Grubb, and A. Lawen The mitochondrial membrane potential (Δψm) in apoptosis; an update Apoptosis 8 2003 115 128
37. H. Ma, Q. Fan, J. Yu, J. Xin, and C. Zhang Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells Am. J. Chin. Med. 41 2013 197 210
38. R.H. Meyers, and D.C. Montgomery Response Surface Methodology 2002 John Wiley and Sons New York
39. L. Mu, T. Elbayoumi, and V. Torchilin Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin Int. J. Pharm. 306 2005 142 149
40. ® copolymer micelles on the bioavailability and multidrug resistance of docetaxel Biomaterials 31 2010 2371 2379
41. ® block copolymers J. Control. Release 94 2004 411 422
42. S. Puttipipatkhachorn, J. Nunthanid, K. Yamamoto, and G. Peck Drug physical state and drug-polymer interaction on drug release from chitosan matrix films J. Control. Release 75 2001 143 153
43. V. Saxena, and M.D. Hussain Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer Int. J. Nanomed. 7 2012 713 721
44. V. Singh, P. Khullar, P.N. Dave, and N. Kaur Micelles, mixed micelles, and applications of polyoxypropylene (PPO)-polyoxyethylene (PEO)-polyoxypropylene (PPO) triblock polymers Int. J. Ind. Chem. 4 2013 1 18
45. X. Tian, and J.H. Wu Tanshinone derivatives: a patent review (January 2006-September 2012) Expert Opin. Ther. Pat. 23 2013 19 29
46. Y. Wang, F. Costanza, H. Wu, D. Song, and Q. Li PEG-poly(amino acid)s-encapsulated Tanshinone IIA as potential therapeutics for the treatment of hepatoma J. Mater. Chem. B 2014
47. X. Wang The expanding role of mitochondria in apoptosis Genes Dev. 15 2001 2922 2933
48. Z. Wei, J. Hao, S. Yuan, Y. Li, W. Juan, X. Sha, and X. Fang Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization Int. J. Pharm. 376 2009 176 185
49. R. Wong Apoptosis in cancer: from pathogenesis to treatment J. Exp. Clin. Cancer Res. 30 2011 87
50. S. Xu, and P. Liu Tanshinone II A: new perspectives for old remedies Expert Opin. Ther. Pat. 23 2013 149 153
51. M. Xu, F.L. Cao, N.Y. Li, Y.Q. Liu, Y.P. Li, and C.L. Lv Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells Asian Pac. J. Cancer Prev. 14 2013 173 177
52. S. Yang, Y.C. Jiang, L. Liu, X. Fang, and C. Wu Hepatitis B virus X protein disrupts the balance of circadian rhythm genes expression in hepatocellular carcinoma Oncol. Lett. 2014
53. X.Y. Yu, S.G. Lin, Z.W. Zhou, X. Chen, J. Liang, P.Q. Liu, W. Duan, B. Chowbay, J.Y. Wen, and C.G. Li Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge Current Drug Metab. 8 2007 325 340
54. S.M. Yun, S.J. Jeong, J.H. Kim, J.H. Jung, H.J. Lee, E.J. Sohn, M.H. Lee, and S.H. Kim Activation of c-Jun N-terminal kinase mediates tanshinone IIA induced apoptosis in KBM-5 chronic myeloid leukemia cells Biol. Pharm. Bull. 36 2012 208 214
55. Y. Zhang, R. Li, X. Ying, W. Tian, H. Yao, Y. Men, Y. Yu, L. Zhang, R. Ju, and X. Wang Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer Mol. Pharm. 8 2010 162 175
56. W. Zhang, Y. Shi, Y. Chen, J. Ye, X. Sha, and X. Fang Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors Biomaterials 32 2011 2894 2906
57. Y. Zhang, P. Jiang, M. Ye, S.-H. Kim, C. Jiang, and J. Lü Tanshinones: sources, pharmacokinetics and anti-cancer activities Int. J. Mol. Sci. 13 2012 13621 13666
58. Y. Zhang, P.X. Jiang, M. Ye, S.H. Kim, C. Jiang, and J.X. Lü Tanshinones: sources, pharmacokinetics and anti-cancer activities Int. J. Mol. Sci. 13 2012 13621 13666
59. Z. Zhang, L. Mei, and S.-S. Feng Vitamin E -α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine Nanomedicine 7 2012 1645 1647
60. L. Zhao, Y. Shi, S. Zou, M. Sun, L. Li, and G. Zhai Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and -α-tocopheryl polyethylene glycol succinate J. Biomed. Nanotechnol. 7 2011 358 365
61. D. Zheng, X. Li, H. Xu, X. Lu, Y. Hu, and W. Fan Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma Acta Biochim. Biophys. Sin. 2009 gmp045
62. L.H. Zhou, Q. Hu, H. Sui, S.J. Ci, Y. Wang, X. Liu, N.N. Liu, P.H. Yin, J.M. Qin, and Q. Li Tanshinone II-A inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer Asian Pac. J. Cancer Prev. 13 2012 4453 4458